-
-
Clinicians are familiar with use of dedicated emergency contraceptive (EC) products such as Plan B One-Step (Teva Pharmaceuticals USA) and Next Choice (Watson Pharmaceuticals), as well as the EC use of the copper T380A intrauterine device (ParaGard IUD, Duramed Pharmaceuticals).
-
How often do you include counseling on long-acting reversible contraceptives in your discussions of birth controls? Look for new opportunities, according to a recent presentation by Michael Policar, MD, MPH, medical director of the University of California San Francisco/Family PACT Program Support and Evaluation in Sacramento.
-
Your clinic has distributed brochures on contraceptive methods, put up posters in the waiting room and exam rooms, and passed out printed information along with pill packs.
-
-
-
-
A news analysis published in CANCER found that black patients with hepatocellular carcinoma (HCC), or liver cancer, have worse survival than patients of other races, even after receiving comparable treatments.
-
From a grassroots organization's efforts to make medical error disclosure and apology part of the U.S. health culture to more hospitals and other health care players are beginning to be aware of apology, and it would appear that more organizations agree that offering an institutional "I'm sorry" is the right thing to do.
-
Some of the thorniest questions that IRBs face are those for which there are no clear-cut answers opinions may vary, arguments on both sides may be compelling, regulatory guidance may be scanty.